|4Mar 4, 2:00 PM ET

LAUDER RONALD S 4

4 · ESTEE LAUDER COMPANIES INC · Filed Mar 4, 2021

Insider Transaction Report

Form 4
Period: 2021-03-02
LAUDER RONALD S
Chairman, Clinique Labs, LLC10% Owner
Transactions
  • Sale

    Class A Common Stock

    2021-03-02$289.97/sh46,370$13,445,90932,001 total
  • Sale

    Class A Common Stock

    2021-03-02$291.09/sh22,127$6,440,9489,874 total
  • Sale

    Class A Common Stock

    2021-03-02$291.82/sh9,874$2,881,4310 total
Holdings
  • Class A Common Stock

    (indirect: By Trust)
    6,364
Footnotes (5)
  • [F1]The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
  • [F2]Sales prices range from $289.45 to $290.31 per share, inclusive.
  • [F3]Sales prices range from $290.49 to $291.48 per share, inclusive.
  • [F4]Sales prices range from $291.51 to $292.42 per share, inclusive.
  • [F5]RSL disclaims beneficial ownership of these shares to the extent he does not have a pecuniary interest in such securities.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT